SCHEMBL22113161

SCHEMBL22113161

CN1[C@@H]2CC[C@@H]1CC(N)C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.55
LMNA P02545 1/20 0.55
SLC6A2 P23975 6/20 0.38
SLC6A3 Q01959 6/20 0.38
MAPK1 P28482 1/20 0.37
CHRM1 P11229 7/20 0.35
CHRM3 P20309 4/20 0.35
SLC6A4 P31645 4/20 0.35
DRD3 P35462 4/20 0.35
CHRM2 P08172 3/20 0.35
HRH1 P35367 2/20 0.35
ADRA2A P08913 2/20 0.35
DRD2 P14416 2/20 0.35
ADRA2B P18089 2/20 0.35
ADRA2C P18825 2/20 0.35
HRH2 P25021 2/20 0.35
ADRA1D P25100 2/20 0.35
HTR2A P28223 2/20 0.35
HTR6 P50406 2/20 0.35
SIGMAR1 Q99720 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL334182 1.00 CYP2C9 (0.55) CYP2C9LMNASLC6A2SLC6A3MAPK1
SCHEMBL21548014 1.00 CYP2C9 (0.55) CYP2C9LMNASLC6A2SLC6A3MAPK1
SCHEMBL1573636 1.00 CYP2C9 (0.55) CYP2C9LMNASLC6A2SLC6A3MAPK1
SCHEMBL13713095 1.00 CYP2C9 (0.55) CYP2C9LMNASLC6A2SLC6A3MAPK1
SCHEMBL372614 1.00 CYP2C9 (0.55) CYP2C9LMNASLC6A2SLC6A3MAPK1
SCHEMBL852253 1.00 CYP2C9 (0.55) CYP2C9LMNASLC6A2SLC6A3MAPK1
Hydrochloric Acid SCHEMBL704299 0.97 LMNA (0.52) CYP2C9LMNASLC6A2SLC6A3MAPK1
Hydrochloric Acid SCHEMBL7624931 0.97 LMNA (0.52) CYP2C9LMNASLC6A2SLC6A3MAPK1
Hydrochloric Acid SCHEMBL1110550 0.97 LMNA (0.52) CYP2C9LMNASLC6A2SLC6A3MAPK1
Hydrochloric Acid SCHEMBL3368724 0.97 LMNA (0.52) CYP2C9LMNASLC6A2SLC6A3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210179634-A1 NOVEL BIPHENYL COMPOUND OR SALT THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-06-17 US disclosed
US-20200190175-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190175-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 INMT, CARM1, KDM1B CYP2C9 3735/4885LMNA 420/4885SLC6A2 2619/4885
US-20210179634-A1 NOVEL BIPHENYL COMPOUND OR SALT THEREOF KDM1B, KDM1A, HDAC1 CYP2C9 1673/4885LMNA 2070/4885SLC6A2 1757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.